Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fischer

Showing results (1301-1310 of 1,361) with videos related to

Pageof 137
Sort By:
Nature Communications|August 7, 2023
Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healingDominic Henn, Dehua Zhao, Dharshan Sivaraj, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Nature|February 26, 2025
Programs, origins and immunomodulatory functions of myeloid cells in gliomaTyler E Miller, Chadi A El Farran, Charles P Couturier, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2024
Endothelial-specific CXCL12 regulates neovascularization during tissue repair and tumor progressionAndrew C Hostler, William W Hahn, Michael S Hu, et al.
Nature Medicine|February 16, 2021
Humoral signatures of protective and pathological SARS-CoV-2 infection in childrenYannic C Bartsch, Chuangqi Wang, Tomer Zohar, et al.
Cancer|March 14, 2018
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptorGlenwood D Goss, Everett E Vokes, Michael S Gordon, et al.
Research Square|April 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT studyIrene Ghobrial, Noe Perron, Michelle Aranha, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference reportA Humar, M Morris, E Blumberg, et al.
Pageof 137

Showing results (1301-1310 of 1,361) with videos related to

Sort By:
Pageof 137
Nature Communications|August 7, 2023
Cas9-mediated knockout of Ndrg2 enhances the regenerative potential of dendritic cells for wound healingDominic Henn, Dehua Zhao, Dharshan Sivaraj, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Nature|February 26, 2025
Programs, origins and immunomodulatory functions of myeloid cells in gliomaTyler E Miller, Chadi A El Farran, Charles P Couturier, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 19, 2024
Endothelial-specific CXCL12 regulates neovascularization during tissue repair and tumor progressionAndrew C Hostler, William W Hahn, Michael S Hu, et al.
Nature Medicine|February 16, 2021
Humoral signatures of protective and pathological SARS-CoV-2 infection in childrenYannic C Bartsch, Chuangqi Wang, Tomer Zohar, et al.
Cancer|March 14, 2018
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptorGlenwood D Goss, Everett E Vokes, Michael S Gordon, et al.
Research Square|April 27, 2026
Myeloma Precursors Erode Durable Immunity: Results of the IMPACT studyIrene Ghobrial, Noe Perron, Michelle Aranha, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Nature Communications|May 8, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trialsWallace Bourgeois, Hannah E Rice, Daniela V Wenge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference reportA Humar, M Morris, E Blumberg, et al.
Pageof 137